Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells as Novel Diagnostic Tools for Non-Alcoholic Fatty Liver Disease: Visualizing Relationships with Known and Potential Disease Biomarkers.
correlation plot
mitochondrial bioenergetics
non-alcoholic fatty liver disease
peripheral blood mononuclear cells
random forest
relative variable importance
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
13 Jul 2023
13 Jul 2023
Historique:
received:
18
06
2023
accepted:
07
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Non-alcoholic fatty liver disease (NAFLD) is a health emergency worldwide due to its high prevalence and the lack of specific therapies. Noninvasive biomarkers supporting NAFLD diagnosis are urgently needed. Liver mitochondrial dysfunction is a central NAFLD pathomechanism that changes throughout disease progression. Blood-cell bioenergetics reflecting mitochondrial organ dysfunction is emerging for its potential applications in diagnostics. We measured real-time mitochondrial respirometry in peripheral blood mononuclear cells (PBMCs), anthropometric parameters, routine blood analytes, and circulating cytokines from a cohort of NAFLD patients (N = 19) and non-NAFLD control subjects (N = 18). PBMC basal respiration, ATP-linked respiration, maximal respiration, and spare respiratory capacity were significantly reduced in NAFLD compared to non-NAFLD cases. Correlation plots were applied to visualize relationships between known or potential NAFLD-related biomarkers, while non-parametric methods were applied to identify which biomarkers are NAFLD predictors. Basal and ATP-linked mitochondrial respiration were negatively correlated with triglycerides and fasting insulin levels and HOMA index. Maximal and spare respiratory capacity were negatively correlated with IL-6 levels. All the mitochondrial respiratory parameters were positively correlated with HDL-cholesterol level and negatively correlated with fatty liver index. We propose including blood cell respirometry in panels of NAFLD diagnostic biomarkers to monitor disease progression and the response to current and novel therapies, including mitochondrial-targeted ones.
Identifiants
pubmed: 37510108
pii: diagnostics13142363
doi: 10.3390/diagnostics13142363
pmc: PMC10378438
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : University of Brescia
ID : SEELN 2015
Organisme : University of Molise, Campobasso, Italy; Professional Dietetics S.p.A, Milan, Italy
ID : co-funding SEELN 2015
Références
Biochem Pharmacol. 2019 Feb;160:34-45
pubmed: 30508523
Sci Rep. 2017 Sep 5;7(1):10528
pubmed: 28874808
Am J Physiol Heart Circ Physiol. 2020 Aug 1;319(2):H481-H487
pubmed: 32678706
BMC Gastroenterol. 2006 Feb 14;6:6
pubmed: 16503961
J Public Health Res. 2017 Jun 16;6(1):881
pubmed: 28660178
Hum Mol Genet. 2012 Dec 15;21(24):5294-305
pubmed: 22983956
Bioanalysis. 2021 Dec;13(24):1781-1783
pubmed: 34355575
Bull Exp Biol Med. 2023 Mar;174(5):628-633
pubmed: 37052855
Microbiome. 2021 May 5;9(1):100
pubmed: 33952353
Curr Obes Rep. 2022 Sep;11(3):126-143
pubmed: 35501558
BMC Gastroenterol. 2006 Nov 02;6:33
pubmed: 17081293
Hepatology. 2007 Apr;45(4):846-54
pubmed: 17393509
Lancet. 2021 Jun 5;397(10290):2212-2224
pubmed: 33894145
Cell Metab. 2015 May 5;21(5):739-46
pubmed: 25955209
Mitochondrion. 2012 Mar;12(2):328-35
pubmed: 22310368
Elife. 2021 Oct 18;10:
pubmed: 34661530
Mol Aspects Med. 2020 Feb;71:100835
pubmed: 31864667
Mech Ageing Dev. 2020 Dec;192:111385
pubmed: 33129798
Clin Exp Med. 2023 Jun;23(2):273-285
pubmed: 35192111
Lancet Diabetes Endocrinol. 2019 Apr;7(4):313-324
pubmed: 30174213
Eur J Cell Biol. 2016 Aug;95(8):252-64
pubmed: 27168348
Biol Psychiatry. 2018 Jul 1;84(1):9-17
pubmed: 29525040
Clin Gastroenterol Hepatol. 2019 May;17(6):1157-1164.e4
pubmed: 30476583
Am J Hum Genet. 2013 Sep 5;93(3):471-81
pubmed: 23993193
Biol Chem. 2019 Dec 18;401(1):3-29
pubmed: 31815377
Circ Res. 2015 Oct 9;117(9):817-24
pubmed: 26358192
J Hepatol. 2016 Jun;64(6):1388-402
pubmed: 27062661
Mol Metab. 2023 Jul;73:101728
pubmed: 37084865
Curr Opin Clin Nutr Metab Care. 2021 Jan;24(1):88-95
pubmed: 33060458
Nat Rev Gastroenterol Hepatol. 2020 Jul;17(7):387-388
pubmed: 32461575
Eat Weight Disord. 2018 Apr;23(2):149-157
pubmed: 29397563
mSystems. 2017 May 9;2(3):
pubmed: 28497122
J Vis Exp. 2014 Mar 27;(85):
pubmed: 24747339
Exp Ther Med. 2014 Sep;8(3):759-762
pubmed: 25120595
J Biol Chem. 2022 Jun;298(6):102008
pubmed: 35513069
Brain Sci. 2022 Mar 19;12(3):
pubmed: 35326364
Methods Enzymol. 2014;547:309-54
pubmed: 25416364
Mitochondrion. 2021 Mar;57:119-130
pubmed: 33387664
Transl Gastroenterol Hepatol. 2021 Jan 05;6:4
pubmed: 33437892
J Clin Exp Hepatol. 2022 May-Jun;12(3):808-817
pubmed: 35677503
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Cell Immunol. 2018 Aug;330:175-182
pubmed: 29454647
J Cardiovasc Med (Hagerstown). 2022 Jul 1;23(7):439-446
pubmed: 35763764
Front Immunol. 2022 May 06;13:880298
pubmed: 35603224
Bioanalysis. 2020 Sep;12(17):1223-1230
pubmed: 32573254
Circ Res. 2008 Feb 29;102(4):401-14
pubmed: 18309108